FIELD: biotechnology; immunology; virology.
SUBSTANCE: following is described: a nucleic acid having promoter activity, having a nucleotide sequence selected from the following group SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15. An expression cassette containing the specified nucleic acid molecule and an operably linked transgene is also described. An expression vector containing the specified nucleic acid or expression cassette is provided. Also, the following is provided: a host cell for producing the target product, containing the said nucleic acid or expression cassette, where the target product is a protein, a small inhibitory nucleic acid or an expression vector.
EFFECT: invention expands the range of promoters.
8 cl, 19 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CODON-OPTIMIZED NUCLEIC ACID THAT ENCODES B-DOMAIN-DELETED FACTOR VIII PROTEIN AND ITS USE | 2022 |
|
RU2808564C2 |
| MODIFICATION OF B-CELLS | 2018 |
|
RU2783116C2 |
| PROMOTER COMPOSITIONS | 2014 |
|
RU2742435C2 |
| LIVER-SPECIFIC STRUCTURES, EXPRESSION CASSETTES OF FACTOR VIII AND THEIR APPLICATION METHODS | 2016 |
|
RU2774874C2 |
| THERAPEUTIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | 2015 |
|
RU2711147C2 |
| GENE THERAPY OF OPHTHALMIC DISORDERS | 2016 |
|
RU2762747C2 |
| RECOVERED NUCLEIC ACID WHICH CODES FVIII-BDD-BASED FUSION PROTEIN AND HETEROLOGOUS SIGNAL PEPTIDE, AND USE THEREOF | 2022 |
|
RU2818229C2 |
| RECOMBINANT DNA ELEMENTS FOR RECOMBINANT PROTEINS EXPRESSION IN THE HOST CELL | 2012 |
|
RU2619161C2 |
| SYNP161, PROMOTER FOR SPECIFIC GENE EXPRESSION IN ROD PHOTORECEPTORS | 2016 |
|
RU2758211C2 |
| MODIFIED CLOSED-ENDED DNA (scDNA) | 2018 |
|
RU2800026C2 |
